Recent news on Nimodipine

Generic Nimodipine Approved  -  Apr 25, 2007
Facts and Comparisons,The FDA has approved Sun Pharma’s ANDA for nimodipine 30 mg capsules, indicated for improvement of neurological outcome by reducing the incidence and

First-Time Generic Approvals: Ambien, Zoloft, Nimotop  -  May 4, 2007
Medscape (subscription)On April 17, the FDA approved the first generic formulation of nimodipine 30-mg soft gelatin capsules (Sun Pharmaceutical Industries, Inc;

Barr Laboratories (BRL) Receives Approval for Generic Nimotop(R ...  -  May 3, 2007
PipelineReview.com (press release),Nimotop (nimodipine) is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with

Generic Nimodipine Approved  -  Apr 25, 2007
Facts and Comparisons,The FDA has approved Sun Pharma’s ANDA for nimodipine 30 mg capsules, indicated for improvement of neurological outcome by reducing the incidence and

The possible mechanisms by which phanoside stimulates insulin ...  -  Dec 13, 2006
Journal of EndocrinologyWhen using nimodipine to block L-type Ca 2+ channels in B-cells, phanoside-induced insulin secretion was unaffected at 3.3 mM glucose but decreased at 16.7

Clazosentan reduces cerebral vasospasm in patients with aneurysmal ...  -  Dec 3, 2006
Xagena.it,...such as fluid retention, also evidenced by excess cases of pulmonary complications, and hypotension, especially when used concomitantly with Nimodipine.

Oregon Researchers Say Drug May Reduce Stroke Risk After Brain ...  09 Nov 2006
The standard therapy for treating subarachnoid hemorrhage has been fluids and nimodipine, a calcium blocker intended to prevent vasospasm by increasing blood ... -MedfordNews.com, FTC Challenges Barr’s Proposed Acquisition of Pliva  Oct 20, 2006
Barr also is required to divest either Pliva’s or Barr’s generic nimodipine for use in treating ruptured blood vessels in the brain. ... -PharmaLive.com (press release), Barr finalizes $2.5 billion deal for Croatian generic drugmaker  Oct 25, 2006
The agency also is requiring the combined company to sell either Pliva's or Barr's generic nimodipine for use in treating ruptured blood vessels in the brain. ... -The Journal News.com, Barr Must Divest Drugs for Pliva Buy OK  Oct 20, 2006
The Woodcliff Lake, NJ-based company also is required to divest either Pliva's or its own version of generic nimodipine, which treats ruptured blood vessels in ... -Houston Chronicle, Actelion to continue clinical trial of Clazosentan  Oct 9, 2006
...events such as fluid retention, also evidenced by excess cases of pulmonary complications, and hypotension, especially when used concomitantly with nimodipine. ... -MarketWatch Barr must divest drugs for final Pliva approval  Oct 20, 2006
Barr also is required to divest either Pliva's or its own version of generic nimodipine, which treats ruptured blood vessels in the brain, and to divest ... -Crain's New York Business, Business Briefs  Oct 20, 2006
Barr, based in Woodcliff Lake, also is required to divest either Pli va's or Barr's generic nimodipine for use in treating ruptured blood vessels in the brain ... -Newark Star Ledger, Barr acquires Pliva, agrees antitrust conditions  Oct 20, 2006
Barr also is required to divest either Pliva's or Barr's generic nimodipine for use in treating ruptured blood vessels in the brain, the FTC said. ... -San Diego Union Tribune, Clazosentan reduces cerebral vasospasm in patients with aneurysmal ...  -  Dec 3, 2006
Xagena.it,...such as fluid retention, also evidenced by excess cases of pulmonary complications, and hypotension, especially when used concomitantly with Nimodipine.

Subcutaneous Apomorphine for Neuroleptic Malignant Syndrome  Jul 28, 2006
Her symptoms did not improve with lithium, quetiapine, lorazepam, nimodipine, and electroconvulsive treatment (ECT). Based on the ... -Am J Psychiatry (subscription)



The Light Peak of the Electroretinogram Is Dependent on Voltage ...  Apr 24, 2006
...of VDCCs in the LP. Nimodipine diminished the LP, leading us to survey VDCC ß-subunit mutant mice. Lethargic mice, which harbor ... - Journal of General Physiology





Clinical Experience of Selective Intra-Arterial Nimodipine ...  Mar 21, 2006
We read with interest the recent report by Firat et al entitled "Selective Intraarterial Nimodipine Treatment in an Experimental Subarachnoid Hemorrhage Model ... - Am J Neuroradiology (subscription)

Dynamic CT Perfusion Imaging in Subarachnoid Hemorrhage–Related ...  Mar 21, 2006
BACKGROUND AND PURPOSE: Nimodipine is a therapy that reduces morbidity and mortality in patients with subarachnoid hemorrhage (SAH), though the mechanisms by ... - Am J Neuroradiology (subscription)



FDA Announces Nimotop (nimodipine) Boxed Warning to Notify ...  Feb 16, 2006
15, 2006--Bayer and FDA notified healthcare professionals of changes to the prescribing information for nimodipine (Nimotop), including a boxed warning to ... - PharmaLive.com,

FDA Requests Nimodipine (Nimotop) Label Change  Jan 31, 2006
BETHESDA, MD -- January 31, 2006 -- The FDA has requested that Bayer add a boxed warning to the nimodipine (Nimotop) labeling to warn about medication ... - DG News

Alert for Healthcare Professionals Nimodipine (marketed as Nimotop ...  Jan 31, 2006
30, 2006-FDA ALERT [1/2006): The FDA has requested that Bayer add a boxed warning to the nimodipine (Nimotop) labeling to warn about medication administration ... - PharmaLive.com

Perioperative Nimodipine and Postoperative Analgesia  Jan 29, 2006
There is experimental evidence that nimodipine, an L-type dihydropiridine calcium channel blocker with relatively high blood-brain barrier penetration ... - Anesthesia & Analgesia (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional